The doctor can see further down your throat via fibre optic laryngoscopy (FOL). The laryngoscope can be stiff or flexible. Flexible laryngoscopes provide a greater view of the throat while also being more pleasant for the patient. In surgery, rigid laryngoscopes are frequently utilized.
It’s being expected that by 2030, the Fibreoptic Laryngoscope market cap will hit USD 1.4 billion at a CAGR growth of about 8.1%.
Covid 19 Impact & Market Status
During this time, the COVID-19 epidemic had a favorable influence on laryngoscope uptake. Healthcare specialists recommended laryngoscopy for airway treatment in patients with COVID-19 infection. As a result, the increase in the number of instances benefitted the industry's revenue growth. Furthermore, the researchers are doing study to see how effective laryngoscopes are in severely ill patients. As a result, the worldwide increase of COVID-19 cases has affected the need for laryngoscopes.
Because of the expanding elderly population with ENT diseases, the existence of well-established healthcare institutions, and government incentives to employ video laryngoscopes in operations, North America dominates the laryngoscopes market. In contrast, Asia-Pacific is expected to develop at a quick and profitable rate, owing to strong demand for minimally invasive operations, increased healthcare awareness, and rising healthcare spending in these countries. Individual market impacting elements and changes in domestic legislation are also addressed in the nation section of the laryngoscopes market report, which have an impact on current and future market trends.
Soft Tissue Injury
The risk of soft tissue damage from a laryngoscope is a stumbling block for the laryngoscope business. The soft palate is the most prevalent problem, but injuries to the teeth, larynx, tongue, and retromolar trigone also occur. The oropharynx is particularly vulnerable to damage because the video laryngoscope elevates and stretches the tonsillar pillars anteriorly, making them more vulnerable to harm as the tube is advanced. The insertion of the laryngoscope causes soft tissue damage in traditional laryngoscopy, but the insertion of the endotracheal tube (ETT) causes soft tissue injury in video laryngoscopy because it is often designed blindly into and through the oral cavity and pharynx until it is finally in view at the end.
A laryngoscope is a medical instrument that examines the voice chords and the larynx of the throat.
The two primary varieties of laryngoscopes on the market are indirect and direct laryngoscopes. The direct laryngoscope is a method that allows surgeons to see the larynx while under general anesthesia. Video laryngoscopes, ordinary laryngoscopes, and fiber-optic laryngoscopes are among the products involved. Hospitals, clinics, and medical examination facilities are among the numerous end-users.
With $0.25 million in 2022, the worldwide fibreoptic laryngoscope market is expected to develop at a CAGR of 10.6%, the worldwide fibreoptic laryngoscope market is estimated to reach USD 380 million in 2029.
One of the major factors projected to drive fibreoptic laryngoscope market growth is the rising frequency of laryngeal malignancies, infections, and chronic respiratory disorders. Laryngeal carcinoma is a kind of head and neck cancer caused by the formation of abnormal (malignant) cells in the larynx. Larynx cancer claimed the lives of 88,878 men and 13,762 women globally in 2019. Furthermore, there were 12,370 new cases and 3,750 fatalities from laryngeal cancer in the United States in 2020. As a result of the rising occurrence of laryngeal cancer, demand for laryngoscopes grew, contributing to market growth.
Abbott, Verathon Inc., BD, HOYA Corporation, Stryker, HOYA VISION CARE COMPANY, HEINE Optotechnik GmbH & Co. KG, Armstrong Medical Inc., Ambu A/S., Rudolf Riester GmbH, SCHLLY FIBEROPTIC GMBH, Medicon eG, Hill-Rom Services, Inc, Teleflex Incorporated, Olympus Corporation, and Henke-Sas are the major players operating in the market.
Latest Innovation in the Fibreoptic Laryngoscope Market: A Snapshot
• The CoPilot VL video laryngoscope was purchased by Dilon Technologies, a global leader in creating, manufacturing, and commercializing novel medical imaging technologies, for an undisclosed sum in January 2019. Dilon Technologies will be able to increase its presence in the anesthetic and airway fields as a result of this purchase. Dilon's CoPilot VL imaging and intraoperative devices, which include the Molecular Breast Imaging Program for breast cancer diagnostics and the Dilon Navigator Gamma Cancer Surgery Probe, are expanding.
Fibreoptic Laryngoscope Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2028||USD 380 million|
|Growth Rate||CAGR of 10.6 % during 2021-2028|
|Segment Covered||Type, Application, Regions|
|Regions Covered||North America, Europe, Asia Pacific, Middle East and Africa, South America|
|Key Players Profiled||Abbott, Verathon Inc., BD, HOYA Corporation, Stryker, HOYA VISION CARE COMPANY, HEINE Optotechnik GmbH & Co. KG, Armstrong Medical Inc., Ambu A/S., Rudolf Riester GmbH, SCHLLY FIBEROPTIC GMBH, Medicon eG, Hill-Rom Services, Inc, Teleflex Incorporated, Olympus Corporation, and Henke-Sas|
Key Segments of the Fibreoptic Laryngoscope Market
Type Overview, 2022-2029 (USD Million)
- Indirect Laryngoscope
- Direct Laryngoscope
Application Overview, 2022-2029 (USD Million)
- Medical Examination Centre
Regional Overview, 2022-2029 (USD Million)
- Rest of Europe
- Rest of Asia Pacific
- Rest of South America
Middle East and South Africa